Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleHealth Med vs Velvet Rx

TeleHealth Med
Graded #209

Higher grade

vs+7.999999999999993
Velvet Rx
Graded #381

Lower grade

The verdict

TeleHealth Med takes it — 66.1/100 to 58.1/100.

TeleHealth Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleHealth Med +32
74
42
Dose & formulationVelvet Rx +12
63
75
Clinical oversightTeleHealth Med +9
76
67
Labs & monitoringVelvet Rx +1
52
53
FulfillmentTeleHealth Med +6
63
57
Contract termsEven
55
55
TeleHealth Med · left barVelvet Rx · right bar

The numbers

MetricTeleHealth MedVelvet Rx
WeighScore66.1/10058.1/100
GradeCC
Scorecard rank#209#381
Semaglutide$147/mo (starting dose, compounded)$299/mo (compounded)
TirzepatideNot disclosed$359/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
TeleHealth Med

Graded #209 · C

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

Where it loses points

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published
Velvet Rx

Graded #381 · C

Strengths

  • Public pricing across 3 SKUs (semaglutide $299, tirzepatide $359, oral GLP-1 $349) — uncommon in compounded telehealth
  • First-month promo pricing shown upfront ($139 sema / $199 tirz / $189 oral)
  • Single monthly price includes consult, prescription, 4 weeks of medication, and free 1–2 day shipping
  • FSA/HSA eligible
  • Three options under one roof: injectable sema, injectable tirz, and an oral GLP-1

Where it loses points

  • Oral GLP-1 SKU doesn't name the specific drug — a real gap given Rybelsus, Foundayo, and compounded oral semaglutide differ clinically
  • No LegitScript or NABP .pharmacy seal displayed
  • No legal entity name disclosed
  • No physical address disclosed
  • Compounding pharmacy partner not named

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard